Core Problem Statement

The global burden of infectious diseases continues to rise due to delayed diagnosis and limited drug-resistance detection, which prevents effective treatment.

Solution Overview

Clinical genomics platform integrating proprietary NGS kits and an AI-driven bioinformatics pipeline that automates data interpretation. The architecture upgrades existing labs into decentralized genomic diagnostic centers, enabling direct-from-sample sequencing for AMR markers in a single run.

Strategic Engagement Opportunities

HaystackAnalytics' infexn®-NGS platform offers diagnostic corporates a proven design-partner for pilot and procurement. It is well-suited for hospital and academic co-validation partnerships to drive clinical genomics and infectious disease research.